PDA

View Full Version : AstraZeneca receives six months pediatric exclusivity patent extension for ARIMIDEX (

News
12-03-2007, 08:10 AM
AstraZeneca has announced that the United States (US) Food and Drug Administration (FDA) has granted an additional six-month period of exclusivity to market ARIMIDEX (anastrozole) for its licensed breast cancer indications until June 2010.

More... (http://www.news-medical.net/?id=33071)